Építés alatt – nem éles oldal
Belépés

What researchers published on Neuromyelitis optica (NMOSD)

4499 papers, newest first.

Showing 140 of 4499

  • Treatment patterns of patients with neuromyelitis optica spectrum disorder switched to inebilizumab in Japan: a claims-based retrospective study.Orphanet journal of rare diseases
  • Nonconvulsive Status Epilepticus in Neuromyelitis Optica Spectrum Disorder Without Cortical Involvement.Journal of clinical neurology (Seoul, Korea)
  • Nursing Protocols and Observed Outcomes of TR-350 Immunoadsorption in Neuromyelitis Optica Spectrum Disorder: A Single-Center Experience of 334 Procedures.Blood purification
  • [A case of anti-AQP4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) complicating diffuse large B-cell lymphoma (DLBCL)].Rinsho shinkeigaku = Clinical neurology
  • Astrocytic TRIM21 downregulation exacerbates NMOSD via potentiating IRF3/IRF7-mediated type I interferon response.Journal of neuroinflammation
  • Mapping myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorders (NMOSD): A global review of publicly listed patient disease registries and databases.Multiple sclerosis (Houndmills, Basingstoke, England)
  • EsetismertetésAquaporin-4-IgG-positive neuromyelitis optica spectrum disorder in an adolescent with inflammatory polyarthritis and Sjögren-related features: a case report.BMC neurology
  • Total Economic Impact of Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.Neurology and therapy
  • Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies.Neurology(R) neuroimmunology & neuroinflammation
  • Cortical Hierarchical Disorganization and Transcriptomic Associations in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders Revealed by Morphometric INverse Divergence Network Gradients.CNS neuroscience & therapeutics
  • EsetismertetésDiagnostic dilemma in the management of a cervical spinal cord lesion: neuromyelitis optica spectrum disorder: a case report.Journal of medical case reports
  • Biologic switching and relapses during biologic therapy in AQP4-IgG-positive NMOSD: a real-world study.Multiple sclerosis and related disorders
  • EsetismertetésIntractable Nausea and Vomiting: A Key Feature of Neuromyelitis Optica Spectrum Disorder.The American journal of case reports
  • PreprintInnate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica.bioRxiv : the preprint server for biology
  • Pregnancy and Disease Activity in AQP4+ Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Multicenter Turkish Cohort.Noro psikiyatri arsivi
  • EsetismertetésNeuromyelitis optica spectrum disorder presenting as rapidly progressive dementia: A case report.Medicine
  • ÁttekintésRole of microglia in neuromyelitis optica (Review).International journal of molecular medicine
  • A Case Report of Early Multimodal Immunotherapy for Rapidly Progressive Neuromyelitis Optica Spectrum Disorder with Extensive Brain Lesions.Internal medicine (Tokyo, Japan)
  • Phenotypic and immunological profile divergence between SLE-associated myelitis and SLE-NMOSD overlap syndrome: a retrospective case series.Frontiers in immunology
  • Association between psychosocial consequences of visual dysfunction and depressive symptom burden in multiple sclerosis and neuromyelitis optica spectrum disorder.Frontiers in neurology
  • AQP4 antibody-induced astrocyte injury reshapes CNS immune architecture in a combined EAE-AQP4-IgG model of neuromyelitis optica spectrum disorder.Frontiers in immunology
  • Proportion and Clinical Characteristics of Double-Seronegative NMOSD in a Multicenter Real-World Cohort.European journal of neurology
  • EsetismertetésCerebral Air Embolism After Double-lumen Catheter Removal for Plasmapheresis: A Case Report.Acta neurologica Taiwanica
  • Phase-associated differences in perivascular and glymphatic-related MRI markers in AQP4-IgG-seropositive neuromyelitis Optica spectrum disorder: A cross-sectional study.Multiple sclerosis and related disorders
  • ÁttekintésLatin American consensus recommendations on the role of magnetic resonance imaging in neuromyelitis optica spectrum disorder in clinical practice.Multiple sclerosis and related disorders
  • Characteristics of serum Metrnl levels in patients with neuromyelitis optica spectrum disorder and their associations with disease activity and inflammatory biomarkers.Frontiers in immunology
  • Efficacy of Fampridine on Refractory Optic Neuritis in Neuromyelitis Optica Spectrum Disorders.Annals of clinical and translational neurology
  • Efficacy and Safety of Multidisciplinary Sandwich Regimen in AQP4-IgG+ NMOSD With Preconception B-Cell Depletion During Perigravidity.CNS neuroscience & therapeutics
  • Isolated Extramedullary Trigeminal Nerve Root Lesion in Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 Immunoglobulin G.The Neurohospitalist
  • Altered intersubject variability of functional connectivity in gray and white matter underlying neurocognition and genetic profiles in neuromyelitis optica spectrum disorder.Neural regeneration research
  • ÁttekintésThe Balance Between Immune Activation and Tolerance in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders and MOG Antibody-Associated Disease.Immunology and cell biology
  • Megfigyeléses vizsgálatRavulizumab in neuromyelitis optica spectrum disorder: first clinical experience in Chile.Frontiers in immunology
  • Investigation of Complement Activation and Cytokine Signatures in AQP4+ NMOSD, MOGAD, and MS.Annals of clinical and translational neurology
  • Soluble TIM-3 and galectin-9 in cerebrospinal fluid are associated with disability at 6 months in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder.Frontiers in immunology
  • Progressive hemifacial atrophy, AQP4-positive NMOSD and suspected Sjögren's syndrome: five-year relapse-free follow-up during rituximab therapy.Acta neurologica Belgica
  • Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD: The Role of Disease Activity in MOGAD.Neurology
  • Characterization of distinct cognitive domain patterns in AQP4-IgG-positive NMOSD: A MoCA-based factor analysis and risk profiling.Multiple sclerosis and related disorders
  • Increased autoimmune disease burden before multiple sclerosis and neuromyelitis optica spectrum disorder diagnosis: A nationwide Korean cohort study.Multiple sclerosis (Houndmills, Basingstoke, England)
  • ÁttekintésRecognizing and Differentiating Area Postrema Syndrome Across NMOSD, MOGAD, and GFAP Astrocytopathy.International journal of molecular sciences
  • Co-occurrence of myasthenia gravis and neuromyelitis optica spectrum disorder: A case series and literature review.Journal of neuroimmunology
  • NOP58 knockdown in microglia is associated with reduced neuroinflammation and synaptic damage in NMOSD.Journal of neuroimmunology
  • Clinical phenotype and treatment response in AQP4-IgG-positive NMOSD and MOGAD: insights from the Italian I-MS&RD registry.Journal of neurology
  • Utility of Blood Neutrophil to Diagnose Bacterial Infections under Satralizumab Treatment for Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Report of Two Cases.Internal medicine (Tokyo, Japan)
  • ÁttekintésWhy repair fails in AQP4-IgG-positive neuromyelitis optica spectrum disease: an astrocyte-centered framework for remyelination and neuroaxonal preservation.Frontiers in immunology
  • Nutritional Status in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.Journal of clinical medicine research
  • Beyond physical disability: the case for systematic mental health screening in the care of NMOSD and MOGAD in Latin America.Multiple sclerosis and related disorders
  • Cerebral Attack With Cortical-Leptomeningeal Involvement and Seizures in AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.Internal medicine (Tokyo, Japan)
  • Case Report: Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B-Cell Depletion Therapy to Ravulizumab.Clinical case reports
  • Blood Glial Fibrillary Acidic Protein in MRI-Negative Attack-Like Episodes of Neuromyelitis Optica Spectrum Disorder.European journal of neurology
  • Nursing Protocols and Observed Outcomes of TR-350 Immunoadsorption in Neuromyelitis Optica Spectrum Disorder: A Single-Center Experience of 334 Procedures.Blood purification
  • Long-term neuropsychiatric outcomes in offspring of mothers with multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study.Multiple sclerosis and related disorders
  • EsetismertetésCase Report: Unplanned pregnancy during treatment with inebilizumab in patients with AQP4-IgG-seropositive NMOSD: report of two cases.Frontiers in immunology
  • How patients with neuromyelitis optica spectrum disease accumulate disability.Multiple sclerosis (Houndmills, Basingstoke, England)
  • Neuromyelitis optica spectrum disorder associated with Kabuki syndrome: First reported case and immunopathogenic considerations.Multiple sclerosis (Houndmills, Basingstoke, England)
  • Randomizált vizsgálatAstrocytic and Axonal Injury Biomarkers in AQP4 Antibody-Positive NMOSD: Insights From PREVENT and CHAMPION-NMOSD.Neurology(R) neuroimmunology & neuroinflammation
  • Teaching NeuroImage: Neuromyelitis Optica Spectrum Disease Presenting as a Tumefactive Thalamic Lesion.Neurology
  • Targeting C3aR/STAT3 signaling attenuates neuroinflammation and reverses neurological impairment in Neuromyelitis optica.Fundamental research
  • MetaanalízisPrevalence of autoimmune comorbidities in aquaporin 4-immunoglobulin G positive neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.Multiple sclerosis and related disorders
  • Top-Down CSF Peptidomics Reveals Disease-Associated Peptide Signatures and Oxidative Modifications in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.Proteomics
  • EsetismertetésNeuromyelitis optica spectrum disorder with positive anti-aquaporin-4 antibodies in the context of long-standing rheumatoid arthritis: A case report.Reumatologia clinica
  • Disease-specific patterns of glymphatic-related dysfunction between multiple sclerosis and neuromyelitis optica spectrum disorder.Frontiers in immunology
  • Complement C5 inhibitor as a rescue therapy for acute NMOSD attacks: a multicenter retrospective cohort study in China.Frontiers in immunology
  • ÁttekintésEculizumab and Ravulizumab During Pregnancy in Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis: Balancing Maternal Disease Control and Fetal Safety.CNS drugs
  • IrányelvOptimizing the management of AQP4 antibody-positive NMOSD: A Canadian consensus.Multiple sclerosis and related disorders
  • ÁttekintésMetabolic reprogramming in neuromyelitis optica spectrum disorder: From astrocyte dysfunction to immune-mediated neuroinflammation.Multiple sclerosis and related disorders
  • Diagnostic delay and poor functional outcomes in late-onset NMOSD: A Thai cohort study.Multiple sclerosis and related disorders
  • Correction to "Neuromyelitis Optica Mimicking Multiple Sclerosis: A Case Report and a Comprehensive Review of the Literature".Clinical case reports
  • EsetismertetésCase Report: Confirmed and suspected heparin-induced thrombocytopenia during therapeutic plasma exchange in neuromyelitis optica spectrum disorder: a single-centre case series.Frontiers in immunology
  • ÁttekintésUse of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations.Nature reviews. Neurology
  • Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.European journal of neurology
  • Meningococcal infection in patients receiving eculizumab or ravulizumab for generalized myasthenia gravis or neuromyelitis optica spectrum disorder: A real-world study of US clinical practice.Journal of the neurological sciences
  • AFRICTRIMS: Should exclusion of NMOSD/MOGAD be a prerequisite for initiating MS disease-modifying therapy? - Commentary.Multiple sclerosis (Houndmills, Basingstoke, England)
  • AFRICTRIMS: Should exclusion of NMOSD/MOGAD be a prerequisite for initiating MS disease-modifying therapy? Yes.Multiple sclerosis (Houndmills, Basingstoke, England)
  • AFRICTRIMS: Should exclusion of neuromyelitis optica spectrum disorder/myelin oligodendrocyte glycoprotein antibody-associated disease be a prerequisite for initiating MS disease-modifying therapy? - No.Multiple sclerosis (Houndmills, Basingstoke, England)
  • Diagnostic Utility of Novel and Established Spinal MRI Signs in AQP4-IgG-Seropositive NMOSD Myelitis.Neurology
  • From Lesion Length to Lesion Pattern in Neuromyelitis Optica Spectrum Disorder Myelitis: Implications for Diagnostic Criteria.Neurology
  • Potential links between gut microbiota-derived propionate and succinate and CXCL8, IL1B, and IL6 in NMOSD: An integrated network pharmacology and mendelian randomization study.Journal of neuroimmunology
  • Elevated ISG15 reinforces RIG-I/MDA5-linked macrophage-microglia crosstalk during blood-brain barrier disruption in neuromyelitis optica spectrum disorder.International immunopharmacology
  • Opsoclonus-Myoclonus-Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder.Movement disorders clinical practice
  • Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.Journal of neurology, neurosurgery, and psychiatry
  • Comparison of iron and myelin changes in U‑fiber regions of relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorders.Journal of neurology
  • Functional and effective connectivity alterations relate to cognitive performance in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.Brain communications
  • ÁttekintésRecognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.Cell death and differentiation
  • Deeper versus broader B cell depletion in neuromyelitis optica spectrum disorder.Nature reviews. Neurology
  • Clinicopathological features of double-seronegative NMOSD with tumefactive demyelination.Multiple sclerosis and related disorders
  • miRNA-34b overexpression alleviates neuromyelitis optica spectrum disorders by regulating the TIA-1-stress granule pathway.Pakistan journal of pharmaceutical sciences
  • Corrigendum to "Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study" [Multiple Sclerosis and Related Disorders, Volume 97 (2025): 106383].Multiple sclerosis and related disorders
  • Multimodal assessment of sleep and regional brain volumes in AQP4-IgG-positive neuromyelitis optica spectrum disorder: An exploratory cross-sectional study.Multiple sclerosis and related disorders
  • MetaanalízisA systematic review and meta-analysis of the efficacy and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.Multiple sclerosis and related disorders
  • Patient education for neuromyelitis optica spectrum disorder using large language models: combining expert assessment and real-world patient interaction.Frontiers in physiology
  • Primary Central Nervous System Histiocytic Sarcoma During Neuromyelitis Optica Spectrum Disorder.Journal of clinical neurology (Seoul, Korea)
  • ÁttekintésMultimodal MRI biomarkers and machine learning in neuromyelitis optica spectrum disorder: a review.Frontiers in neurology
  • EsetismertetésMovement-Provoked Paroxysmal Neuralgia Following Longitudinally Extensive Transverse Myelitis in Neuromyelitis Optica Spectrum Disorder: A Presumed Ephaptic Spinal Cord Phenomenon.Cureus
  • ÁttekintésNeuromyelitis optica spectrum disorder overlapping with Sjögren's disease: immunopathological links and therapeutic implications.Frontiers in immunology
  • Reduced FOXP3 expression and its association with genetic ancestry in neuromyelitis Optica spectrum disorder: a Colombian cohort.Multiple sclerosis and related disorders
  • ÁttekintésGlobal trends and emerging hotspots in neuromyelitis optica spectrum disorder diagnostic research: A bibliometric analysis.Medicine
  • Aging of the Patients with Neuromyelitis Optica Spectrum Disorder in the Noto Peninsula, Japan.European neurology
  • EsetismertetésEarly Inpatient Rehabilitation Following Neuromyelitis Optica Spectrum Disorder Flare: A Case Report.Cureus
  • Neuromyelitis optica spectrum disorder patients dyadic coping patterns: a latent profile analysis.Frontiers in psychology
  • Altered Blood-Brain Barrier Water Exchange in Remission-Phase Neuromyelitis Optica Spectrum Disorder: A WEPCAST MRI Study.European journal of radiology
  • Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan.Neurology and therapy
  • Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation.Diagnostics (Basel, Switzerland)
  • The Comprehensive Live Cell-Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD.Annals of clinical and translational neurology
  • Irányelv[Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents].Medicina
  • ÁttekintésDe-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.Neurology
  • Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models.Science translational medicine
  • IrányelvNMOSD and MOGAD in Latin America: A consensus-informed regional perspective.Multiple sclerosis and related disorders
  • Inebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study.Annals of clinical and translational neurology
  • EsetismertetésPediatric Post-COVID-19 Neuromyelitis Optica Spectrum Disorder: A Case Report.Cureus
  • Age-stratified clinical characteristics and disability outcomes in neuromyelitis optica spectrum disorder: A cross-sectional study.Acta neurologica Belgica
  • Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorder: Real-World Clinical Outcomes and Safety From a Tertiary Care Center in Northwest India.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
  • ÁttekintésOCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy.Frontiers in medicine
  • ÁttekintésIntractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
  • Prevalence of neuromyelitis optica spectrum disorder in Fujian, China, 2021-2023: a population-based study.Neuroepidemiology
  • EsetismertetésCase Report: Pharmacological decision-making in pregnant women with neuromyelitis optica spectrum disorder: two contrasting clinical scenarios.Frontiers in pharmacology
  • Clinical and serological features of systemic autoimmune overlap in AQP4-IgG positive neuromyelitis optica spectrum disorder: a Mexican cohort study.Multiple sclerosis and related disorders
  • ÁttekintésUse of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.Neurology(R) neuroimmunology & neuroinflammation
  • Randomizált vizsgálatObinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.Nature medicine
  • Complement C3 inhibitory peptide AMY-101 ameliorates brain injury in a mouse model of NMOSD.Annals of medicine
  • Data-augmented machine learning refines the effective-concentration estimate for eculizumab in complement-mediated diseases.Frontiers in immunology
  • Neuromyelitis optica spectrum disorder and autoimmune glial fibrillary acidic protein astrocytopathy overlap syndrome mimicking a pontine mass: The utility of brainstem biopsy.Annals of the Child Neurology Society
  • EsetismertetésNeuromyelitis optica presenting with mammillary body and cervicomedullary lesions after severe hyponatremia mimicking osmotic demyelination syndrome.Radiology case reports
  • Roles of cerebrospinal fluid metabolites in neuromyelitis optica spectrum disorder: Insights from Mendelian randomization.Medicine
  • EsetismertetésCoexistence of Neuromyelitis Optica Spectrum Disorder and Proliferative Lupus Nephritis: A Rare Case Report.The Journal of the Association of Physicians of India
  • EsetismertetésExpanding the Spectrum: Isolated Acute Diencephalitis as the Initial Manifestation of Neuromyelitis Optica Spectrum Disorder.The Journal of the Association of Physicians of India
  • Ravulizumab rescue therapy in a refractory AQP4-positive neuromyelitis optica attack with extensive encephalomyelitis.Revue neurologique
  • A Multidisciplinary Neuropsychology-Neuroimmunology Clinic Model for Pediatric Neuroimmune Disorders.Pediatric neurology
  • Update on the Incidence of Paediatric Multiple Sclerosis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Other Acquired Demyelinating Syndromes in the Netherlands, 2017-2025, Including the COVID-19 Pandemic.European journal of neurology
  • High early mortality and contributing factors in seropositive neuromyelitis optica spectrum disorder at a tertiary hospital in Zambia.Multiple sclerosis and related disorders
  • Risk of Peripheral Artery Disease and Venous Thromboembolism in Patients with Neuromyelitis Optic Spectrum Disorder: A Nationwide Population-Based Cohort Study.International journal of medical sciences
  • Megfigyeléses vizsgálatPatient-reported outcomes in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder on inebilizumab therapy: a cross-sectional study.BMC neurology
  • EsetismertetésArea postrema syndrome and longitudinally extensive transverse myelitis masquerading as leptomeningeal carcinomatosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
  • Predictors for the severity of acute aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorders: a prospective cohort study.Frontiers in immunology
  • EsetismertetésCase Report: AQP4-IgG-positive neuromyelitis optica spectrum disorder with CSF anti- NMDAR1 IgG positivity and encephalitic features.Frontiers in immunology
  • Evaluation of Dried Plasma Spot-Based Quantification of Glial Fibrillary Acidic Protein as a Disease-Associated Biomarker in Neuromyelitis Optica Spectrum Disorder.Annals of clinical and translational neurology
  • MetaanalízisImpact of smoking on clinical outcomes in NMOSD and MOGAD: A meta-analysis.Multiple sclerosis and related disorders
  • Trends in Clinical Indications for Plasma Exchange in Adult Patients Between 2008 and 2024 in Bogotá, Colombia.Journal of clinical apheresis
  • Correction to "Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica".Annals of clinical and translational neurology
  • Megfigyeléses vizsgálatAcute transverse myelitis excluding MS, NMOSD and MOGAD: A 15-year real-world cohort from Iran.Multiple sclerosis and related disorders
  • The immunological landscape of the area postrema in neuromyelitis optica spectrum disorders.Brain pathology (Zurich, Switzerland)